116 Research Drive
3 articles about Azevan Pharmaceuticals
Across the Pharm Country Hotbed, the agency has provided hundreds of millions of dollars to universities, research institutes and pharmaceutical companies.
Azevan Pharmaceuticals Reports Positive Phase 2 Exploratory Clinical Study Results With SRX246 In Intermittent Explosive Disorder
Azevan Pharmaceuticals Completes Enrollment In Phase 2 Clinical Study Of SRX246 In Intermittent Explosive Disorder